Experiments (ARRIVE) guidelines to evaluate the quality of reporting of recent gastric cancer animal experiments. Materials and Methods: A literature search of studies was performed using the Chinese Biomedical Literature Database, Chinese Journal Full-text Database, Chinese Scientific Journal Full-text Database, and Wanfang Database from January 2010 to December 2012. We extracted data using pre-prepared Excel dataextraction forms. Reporting quality was evaluated based on the ARRIVE guidelines.
21 Results: Of the 1816 studies that were identified by our search, 170 were subjected to quantitative analysis 22 using the ARRIVE guidelines. The results of the evaluation based on the ARRIVE guidelines were that 132 23 studies (77.61%) provided an accurate and concise description of baseline conditions and clinical conditions. 24 Only 2 (1.18%) papers provided relevant certificates of ethical review or institutional guidelines, and 2 (1.18%) 25 papers provided an explanation of animal experiments requiring algorithms and formulas for sample size. 26 Forty-seven (27.65%) studies described in detail how animals were assigned to each experimental group, 27 including the randomization procedure, 2 (1.18%) reported whether blinding was used, and 15 (8.82%) 28 evaluated the limitations of the study.
29 Conclusions: The reporting quality of recent animal experiments of gastric cancer is inadequate. We should 30 improve not only the quality of the methodology but also the reporting quality of the animal experiments. 
41
Among all cancers, gastric cancer is one of a few that has high morbidity, and it ranks second only to lung 42 cancer in terms of mortality worldwide (Global et al.,2003) . In China, from 2004 to 2005, gastric cancer had 43 the third highest mortality rate of the 10 main malignant neoplasms (Mortality et al.,2012) .
44
Early diagnosis of gastric cancer is very important for enhancing survival and quality of life. However, 45 most gastric cancer is diagnosed at an advanced stage (Zheng et al., 2015) . In preclinical studies, animal 46 experiments provide a significant reference for clinical research of GC. Clinical research demands 47 improvements in the quality of preclinical research, and progress can be made if clinicians can find ways to 48 improve communication with animal researchers, whose pre-clinical work they may rely on (Perel et al., 2007) . 49 In addition, developing an appropriate animal model and scientific methodology are keys to optimizing the 50 value of gastric cancer research.
51
An increasing number of papers involving animal experiments of gastric cancer have been published in 52 biomedical journals. However, the reporting information remains insufficient in many publications (Berglundh 53 et al., 2012) . A recent study showed that only one in five studies use a blind outcome assessment, and only one 54 in six controlled animal studies use randomization (Macleod et al., 2010) . The scientific and practical value of 55 many animal experiments cannot be maximized because of poor reporting quality. Furthermore, in systematic 56 reviews of animal experiments, poor reporting quality makes it difficult for reviewers to accurately assess the 57 quality of the methodologies of the included studies. The Animals in Research: Reporting In Vivo Experiments 58 (ARRIVE) guidelines, which were based on the Consolidated Standards of Reporting Trials (CONSORT) 59 statement (Thoma et al.,2012; Schulz et al.,2010; Moher et al.,2001) , were funded and developed by the 60 National Centre for the Replacement, Refinement, and Reduction of Animals in Research (NC3Rs) to improve 61 reporting standards (Baker et al.,2014) . The ARRIVE guidelines consist of a 20-item checklist evaluating six 62 parts of a report, including the "Title", "Abstract", "Introduction", "Methods", "Conclusions", and "Discussion" 63 sections. Evaluation of the content includes the number and specific characteristics of the animals used in the 64 experiments (including species, strain, sex, and genetic background), the details of housing and husbandry, and 65 the experimental, statistical, and analytical methods (including the use of randomization and blinding to reduce 66 bias). The ARRIVE guidelines are applicable not only for reporting but also for designing animal experiments.
67
Therefore, the aim of our study was to conduct a systematic review based on the ARRIVE guidelines for 68 the reporting of data in animal experiments on gastric cancer and to analyse the reporting quality of gastric 69 cancer in Chinese journals.
71 Materials and Methods

Inclusion and Exclusion Criteria
We included all animal experiments in gastric cancer that were published in Chinese journals between 74 January 2010 and December 2012. Participants: mice, rats, and nude mice with gastric cancer; no humans; 75 Intervention: no limitations; Comparisons: no limitations; Outcomes: no limitations; Study design: animal 76 experiments. We excluded animal experiments that focused on induced tumours rather than primary tumours, 77 those without specific interventions, those without comparison groups, and those conducted in vitro.
79 Database Search for Published Studies
80
We searched the published animal experiments in gastric cancer from January 2010 to December 2012 in 81 the Chinese Biomedical Literature Database (CBM), the Chinese Journal Full-text Database (CJFD), the 82 Chinese Scientific Journal Full-text Database (CSJD), and the Wanfang Database. The main search terms were 83 as follows: "mouse", "rat", "nude mouse", "animal experiments", "vivo experiments", and "basic research". 84 We used Endnote X4(http://www.down12.com/soft/2066.html) to manage the search results. The search 85 strategy is presented in Appendix Text S1.
87 Selection of Studies
88
The search results were independently selected by two reviewers (Feng Yuchen and Zhang Lili). First, 89 titles and abstracts were selected from a list based on the inclusion and exclusion criteria. Second, the full texts 90 of the studies were reviewed based on the same criteria. Discrepancies were resolved through discussion (with 91 Liu Yali).
93 Data Extraction and Evaluation of Quality
94
We predesigned a unified data-extraction form consisting of basic information (published journals and 95 date, research institutions, first author) and information about reporting quality based on the ARRIVE 96 guidelines (title, abstract, introduction, methods, results, and conclusions.) The ARRIVE guidelines consist of 97 39 sub-items in six sections evaluating the minimum information that all reporting of animal experiments 98 should include (Kilkenny et al.,2010) . We added an item to the checklist's 11th sub-item (marked as 6f) to 99 address whether the experiment designer applied blinding in the experimental process. Each item was assessed 100 as 'yes' (if described in the animal experiment), or 'no' (if not described in the animal experiment). Thus, a 101 total of 40 sub-items were assessed in our study. A point was given for each 'yes', for a total of 40 possible 102 points. Extraction was performed independently by at least two reviewers. Disagreements concerning the 103 suitability of an article were resolved by group discussions.
105 Data Processing and Statistical Methods
106
The ARRIVE score for each sub-item and its frequencies were calculated and expressed as the mean 107 value ± standard deviation. The t-test was used for the review of subgroups. P-values less than 0.05 were 108 considered statistically significant. Statistical analyses were performed using SPSS (version 20.0) and 109 Microsoft Excel (version 2007) software.
Results
Search Results and Screening
113
The results of the search and screening procedure are shown in Figure 1 . A total of 1816 studies were 114 identified by the electronic search. After duplicate studies were removed, 1109 studies remained. We then read 115 titles, abstracts, and full texts based on the inclusion and exclusion criteria. Ultimately, 170 studies met the 116 inclusion criteria and were included in this study. 117 118
Basic Information
120
The characteristics of the included studies are shown in Table 1 . Most of the studies (91.76%, 156/170) 121 included a randomization of the subjects into groups. However, only 19 of the 156 (12.18%) studies described 122 the method of randomization in detail (such as a random number table).
124 General Reporting Information
125
After assessing the included studies according to the ARRIVE guidelines, the results showed that the 126 mean checklist score of studies published from 2010 to 2012 was 21.92 ± 3.01. However, there was no 127 significant difference in the ARRIVE checklist score for studies published in 2010 and 2011 (P > 0.05) or for 128 studies published in 2011 and 2012 (P > 0.05) ( Table 2 ).
129 Reporting Information of "Methods"
130
Only 1.18% of all 170 included studies reported an ethical statement, such as the ethical review 131 permission, relevant licenses, or national or institutional guidelines for animal care and use pertaining to the 132 research. Concerning the study design, almost no studies used a time-line diagram or flow chart to illustrate 133 how the study design was implemented. Of the 169 (99.41%) studies that reported information regarding drug 134 formulations and doses, sites and routes of administration, anaesthesia and analgesia, surgical procedures, and 135 methods of euthanasia, only 5.29% (9/170) provided an explanation of these aspects. We found that only 0.59% 136 (9/170) of the included studies explained how the sample size was determined and provided details regarding 137 any sample size calculation used. Full details describing how animals were assigned to experimental groups 138 were reported by only 27.65% (47/170) of all included studies. Only 1.18% (2/170) of all included studies 139 provided information regarding whether they used blinding to reduce bias. Concerning the quality of the 140 statistical analysis, our results indicated that 20% (34/170) of all included studies provided details regarding 141 statistical methods and described any methods used to assess whether the data met the assumptions of the 142 statistical approach.
143
144 Reporting Information of "Methods"
145
Baseline data, such as each experimental group, relevant characteristics, and the health status of the 146 animals (e.g., weight, microbiological status, and drug-or test-naive) prior to treatment or testing, were 147 reported and tabulated in 10% (17/170) of all included studies. In 38.82% (66/170) of all included studies, the 148 numbers were analysed, and missing animals or data were explained. Only 5.29% (9/170) of all included 149 studies provided any information regarding adverse events.
150
151 Reporting Information of "Conclusions"
152
Comments about study limitations, including any potential sources of bias, any limitations of the animal 153 model, and any imprecision associated with the results, were provided in 8.82% (15/170) of all included 154 studies. All funding sources were listed, and the roles of the funders of the study were described in 55.88% 155 (95/170) of all included studies.
157 Discussion
158
The ARRIVE guidelines were developed and funded by the NC3Rs to improve bioscience research 159 reporting and the communication of research findings to the broader scientific community. However, our 160 survey indicated that the reporting of recent gastric cancer animal research in China is not satisfactory. In 161 particular, the "ethical statement", "statistical methods", and "experimental design" methods, such as 162 randomization and blinding, were not sufficiently described. Some studies focusing on the reporting quality of 163 animal experiments after 2010 in the area of periodontology, such as implant dentistry, have been assessed 164 using the ARRIVE and modified ARRIVE guidelines 
166
Missing experimental methods was the most serious problem identified in the recent animal experiment 167 studies that were assessed. In particular, the ethical statement, sample size (especially regarding how the 208 animals are assigned to each experimental group.
209
There were some limitations in our study. Our research assessed animal experiments from only 2010 to 210 2012, and it was limited to gastric cancer. Our assessment process was not blinded. Our assessment criteria 211 (yes or no) did not use partial information, such as a 0.5 score. Although we assessed reporting quality based 212 on the ARRIVE guidelines, we failed to consider the weight of different items.
214 Conclusions
215
The results indicate that the reporting quality of animal experiments in gastric cancer in Chinese journals 216 was inadequate and that much of the key information was missing, specifically concerning the experimental 217 design, statistical analysis, and ethical terms. Therefore, the reporting quality of biomedical research needs 218 immediate improvement. The ARRIVE guidelines should be used widely to improve the quality of animal 219 experiments and experimental design, and they can also enhance the quality of systematic reviews of animal 220 experiments.
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